0001615219-16-000143.txt : 20160325 0001615219-16-000143.hdr.sgml : 20160325 20160325143010 ACCESSION NUMBER: 0001615219-16-000143 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160322 FILED AS OF DATE: 20160325 DATE AS OF CHANGE: 20160325 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Flex Pharma, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-874-1821 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Westphal Christoph H CENTRAL INDEX KEY: 0001291961 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 161529467 MAIL ADDRESS: STREET 1: C/O ALNYLAM PHARMACEUTICALS, INC STREET 2: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4/A 1 wf-form4a_145893059937882.xml FORM 4/A X0306 4/A 2016-03-22 2016-03-23 0 0001615219 Flex Pharma, Inc. FLKS 0001291961 Westphal Christoph H C/O FLEX PHARMA, INC. 800 BOYLSTON STREET BOSTON MA 02199 1 1 1 0 President and CEO Common Stock 2016-03-22 4 P 0 23951 11.78 A 2910955 I See notes The Form 4 filed on March 23, 2016 reported the purchase of 23,951 shares on March 21, 2016. This Amendment is being filed to correct the date of purchase. The rest of the information disclosed in the original filing for this purchase, including the footnotes, remains the same. /s/ Robert Hadfield, Attorney-in-Fact 2016-03-25